Tom is a former pharmaceutical executive with 30 years of experience across marketing, sales, enterprise services and project leadership, with 16 years of that time spent working in HIV. Having served in several senior executive roles, he brings a broad range of functional expertise as well as HIV experience in international markets including Western and Eastern Europe, Africa, Asia, South America, and Australia.
Most recently, Tom oversaw Global Portfolio Strategy for ViiV Healthcare where he shaped the portfolio vision and integration of ViiV medicines. Prior to that, Tom led the global commercial efforts on the Dolutegravir franchise of HIV medicines including new product introductions in regions around the world. Highlights included interaction with global HIV treatment experts and community members, reimbursement of medicines across major markets, and adoption of dolutegravir as a global treatment standard of care by WHO and UNAIDS.
Tom is known for clever strategies, critical thinking, team leadership, and ability to communicate and collaborate with stakeholders of all levels.
Tom has an MBA from Darden Graduate School of Business Administration, University of Virginia and a BS in Geological Sciences from the University of Texas at Austin